AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGEN CORP Director's Dealing 2022

Dec 23, 2022

32081_dirs_2022-12-23_351bba9f-414e-4c11-b859-ac5c5622c3f6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NEOGEN CORP (NEOG)
CIK: 0000711377
Period of Report: 2022-12-13

Reporting Person: Naemura David H. (VP & CFO)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock (Right to Buy)	$15.49	2025-11-29	Common Stock (172413)		Direct
Restricted Stock Units	$15.49	2025-11-29	Common Stock (38735)		Direct

Footnotes

F1: Options were granted 11/29/2022, have three year lives,and vest in equal annual installments on each of the first three anniversary dates of the grant

F2: RSUs were granted 11/29/2022, have three year lives, and vest in equal annual installments on each of the first three anniversary dates of the grant